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INTRODUCTION 
We will not be wrong in saying that 21^' 
century is an age of stress and strain, because 
collectively as well as individually we are 
experiencing rapid changes.New demands 
and competitive life-style, place a heavy 
burden on the individuals adjustment 
mechanism, therefore vmbelievable energy is 
consuming in coping with stresses, drained 
out and fatigued, the individual experiences 
the state commonly termed as "Depression" 
that has become a common everyday word today. 
http://wwwdateline.ucdavis.edu/0 
10700/DLdepression 
Depression is an emotional condition of lowered and unpleasant psychological 
activity either normal or pathological. The normal manifestation preferably termed 
dejection; refers to a discouraged or dispirited mood; pathological usage refers to a 
mood of pronounced hopelessness and overwhelming feeling of inadequacy or 
unworthiness. The central features of depression includes, feelings of hopelessness 
and worthlessness, inadequacy or guilt, social withdrawl, isolation, irritability and 
short temper, especially when present with anxiety suicidal thoughts, inability to 
make decision or concentrate, inattention to personal hygiene etc. It is an abnormal 
frame of mind that views the world in consistently negative and pessimistic ways that 
leads to inability to work or react normally in life situations. 
A 2000 study by Warwick and Cooper determined that 2.5% of childrens and 8.3% of 
Adolescents live with depression. Of course, adolescence is not the most ideal time to 
become distracted or otherwise dysfunctional .The sapping of motivation involved in 
depression can seriously affect schooling, thereby putting the youth back in their 
studies and furthering the depressive cycle by suggesting the student's academic 
worthlessness. Depression does affect academic performance.Most youth with 
depression also inhibit other behavioral problems. Warwick reports that 15% also 
have anxiety disorder, 50% have oppositional disorder, 33% have a conduct disorder 
and 25% have substance abuse problems. Episodes of depression have 70% chance of 
relapsing in five years and most childhood depressives also experience depression in 
adulthood .Studies over the past five years have only reinforced the position that 
depression in any age population is significant and largely misunderstood. 
It is quite possible that some societies are more prone to the development of 
depressive disposition than others (Burton, 1967).Depressive illness are much less 
fi-equent among negroes than among whites (Field, 1960).Accordingly, the fact that 
depressive disorders are relatively less prevalent among the economically 
underprivileged (Duhnam, 1959), and in technological backward areas (Wittkower 
and Fried, 1959), may be applied as partial explanation of what at first glance appears 
to be a racial difference. People with high intellectual and social aspirations have been 
reported to be slightly more prone to develop depression, such individuals feel 
"crushed" when they fail (Woodruff et al.l971). The person who has no hope of 
replacing outcomes , reducing and/ or reasserting control is likely to exhibit 
symptoms of helplessness, depression, withdrawal ,and so on (Wortman and 
brehm,1975).Borstein (1973) found that even after 13 months, 17 percent of widows 
were depressed. 
According to WHO (2005), in India, the prevalence of serious mental illness is about 
10 to 20 per 1000 of the population. Despite India's National Mental Health 
programme (NMHP) which was introduced almost 30 years ago, provision of services 
are severely lacking. Twenty percent of the districts have implemented the district 
mental health programme plan and only 10% of those who need urgent mental health 
care are receiving the required help with the existing services. Morever, huge 
disparity in access to mental health care exists as the concentration of facilities and 
services is greater in urban areas. Some of the identified barriers for the 
implementation of National Mental Health programme( NHMP )are poor fiinding, 
limited undergraduate training in psychiatry, inadequate mental health human 
resources, limited number of models and their evaluation, uneven distribution of 
resources across states,non-implementation of mental health act 1987, and 
privatisation of healthcare in the 1990s. 
World health organization (WHO), compares depression with epidemic outbreaks 
spread in the whole world .Depression takes the lead among reasons for absence fi-om 
work and is rated second among incapacitating illness. If relevant measures are not 
taken in time, by 2020 the depression would have paralyzed the economics of both 
developed and developing countries. Every year about 150 million people in the 
world become incapable of work because of depression..Because of it only the 
economics of US suffers an estimated 50 million dollar loss annually .This amounts 
includes the costs of 290 lost working days, psychotherapeutic aid and worsening 
work quality. According to WHO's Forecast, by 2020 the depression would have 
taken the first place among all diseases leaving behind today's leaders infectious and 
cardiovascular diseases. 
According to American psychiatric Association presently in the US more than 15 
million people suffer depression. In the US, Canada and most countries of Western 
Europe about 80% of antidepressants are prescribed by general practioners, not 
psychiatrists. According to research carried out in the US, people who are susceptible 
to depression are at twice the risk of dying of other diseases. About 50% of all people 
suffering fi-om depression never seek medical aid, and only 25-30% of visit a 
psychiatrist. Unipolar depression is a leading reason for disability among childrens 
above 5 years old. Special researches show that 60% of all the patients seeking 
medical care have depression symptoms of various levels of severity. Meanwhile, the 
traditional medical methods used in clinics allow to detect depression only in 5% of 
depressive patients who turn there. 
The Diagonastic and statistical Manual of Mental disorders fourth edition (American 
Psychiatric Association, 1994), also called DSM-IV more precisely classifies 
depression with these criterias. 
DIFFERENCE BASED ON GENDER 
Depression in women: 
Depression is more common among women than among men. Hormonal and 
psychosocial factors unique to women may be linked to the higher depression rate in 
women. Reseachers have shown that hormones directly affect brainchemistry that 
controls emotions and mood. For example, women are particularly vulnerable to 
depression after giving birth, when hormonal and physiological changes, along with 
new responsibility of carrying for a newborn, can be overwhelming. Many mothers 
experiencing a brief episode of the" baby blue" but some will develop postpartum 
depression, a much serious condition that requires active treatment and emotional 
support for the new mother. Some studies suggest that women who experience 
postpartum depression often have had prior depressive episodes.Some women may be 
susceptible to a severe form of premenstrual syndrome (PMS), sometimes called 
premenstrual dysphoric disorder (PMDD), a condition resulting from the hormonal 
changes that typically occur around ovulation and before menstruations begins. 
During the transition into menopause, some women experience an increased risk for 
depression. Scientists are exploring how the cyclical rise and fall of estrogen and 
other hormones may affect the brain chemistry that is associated with depressive 
illness. Finally, many women face the additional stresses of work and home 
responsibilities, abuse, poverty and relationship strains. 
Depression in men: 
Men often experience depression differently than women and may have different 
ways of coping with symptoms.Men are more likely to acknowledge having fatigue, 
irritability, loss of interest in once-pleasure activities, and sleep disturbances, whereas 
women are more likely to admit to feelings sadness, worthlessness, and /or excessive 
guilt. 
TYPES OF DEPRESSION ILLNESS: 
The Diagonastic and statistical Manual of Mental disorders, fourth edition (American 
Psychiatric Association, 1994), also known as DSM-IV recognised 9 types of 
depressive illness, which are given below. 
(1) Manic- depressive illness: 
It is defined in terms of its course, or the medical history of the patient.The 
depressive symptoms consists of self-condemnation and ideas of sin and guilt. 
(2) Involutional Melancholia: 
It is a disorder which is defined in terms of age of the patient .It is characterized by 
worry, anxiety, agitation and severe insomnia (Kalpan and Sadock, 1973). 
(3) Psychotic depressive reaction: 
This diagonasis distinguished a depressed mood which is accompanied by impaired 
reality, testing or social adjustment that is of psychotic proportions. 
(4)Agitated depression: 
It is characterized by restless overactivity, sustained tension, despair and apprehensive 
or self-condemnatory delusions, but without serious behaviour disorganization and 
without an adequate basis in organ or tissue pathology. 
(5)Retarted depression: 
The patient slow down looses all interest, in work and recreation and becomes 
gloomy, sad, dejected, withdrawn and preoccupied, moreover gastrointestinal motility 
is greatly slowed up, persistent anorexia and constipation are the rule, salivary and 
sebaceous secretion often diminished (G. Henry, 1931). 
(6) Neurotic depression: It is an excessive reaction of depression which is 
attributable to an intemal conflict or to an identifiable event such as the loss of a love, 
object or cherished possession (Gutheil, 1959). 
(7)Dysthyinic disorder: 
This type is also called dysthymia, and is characterized by long-term (two years or 
longer) but less severe symptoms that may not disease a person but can prevent them 
fi-om functioning normally or feeling well.People with dysthymia may also experience 
one or more episodes of major depression during their lifetimes. 
(8) Postpartum depression: 
Postpartum depression is diagnosed if a new mother develop a major depressive 
episode within one Month after delivery.lt is estimated that 10-15% of women 
experience postpartum depression after giving birth. 
(9)Season affective disorder: 
It usually occurs during the winter months when there is less natural sunlight. For 
that reason it may be called "recurrent depressive disorder with sexual pattern" 
people feel depressed, sleep more and may crave starchy foods and sweets. The 
depression lifts during spring and summer .SAD may be effectively treated with light 
therapy, in which patient is exposed to a bright lamp for short time each day. 
Antidepressant medication and psychotherapy can reduce SAD symptoms either alone 
or in combination with light therapy. 
GENETIC CAUSES OF DEPRESSION: 
Dqjression and other mood disorders tend to proliferate as a result of multiple, 
complex, biological, psychological and social factors, including war and other violent 
conflicts, natural disasters, poverty and limited access to resources. A combination of 
genetic and environmental factors join to imchain depression (Sullivan et al., 2000; 
Wong and Licinio, 2001; Lesch, 2004; Hamet and Tremblay, 2005; Ebmeier et al., 
2006). Multiple susceptibility genes of major or small effect, in interaction with each 
other and in conjunction with environmental events, produce vulnerability to the 
disorder. A significant determinant of depression is the individual's "personal 
threshold," or vulnerability to depression. Some people are more likely than others to 
become depressed, but no one is immune. Depression can affect individuals at any 
stage of the life span, although the incidence is highest during middle age. There is, 
however, an increasing recognition of depression during adolescence and young 
adulthood (Lewinsohn et al., 1993; Taylor et al.,2002).Based on family aggregation 
and contrasting results fi:om studies in monozygotic and dizygotic twins, major 
depression has an estimated heritabilities of 40-50% (major depression) and 40-80% 
(bipolar disorders). Traditional genetic linkage studies and candidate gene methods 
have been used with fairly limited success in major depression. Genetic models of 
etiology generally assume a large number of genes with relatively small contributions 
to liability. Advances in high throughput genotyping and microarray techniques have 
made it more feasible to identify genes with small effect sizes (Hong and Tsai, 
2003).Of special clinical interest are those studies that are based on 
pathophysiological notions (candidate genes) and in particular those that examine the 
probability of patients to respond to particular treatments. Genetic vulnerability may 
involve serotonin (5-HT) systems because tryptophan depletion in healthy subjects is 
reported to induce depressive symptoms only if they have affected relatives 
(Benkelfat et al., 1994).Allelic variations in the serotonin transporter (5-HTT) gene 
are of great interest in depression. A polymorphism in the 5' promoter region 
consisting of a short (s) and a long (L) L-allele with the s-allele being associated with 
decreased 5- HT transmembrane transport and reduced transporter mRNA has been 
described..The gene firequencies in Causasians have been reported to be 41% s-allele 
and 59% L-allele (Mellerup et al., 2001).The s-allele has been associated with 
neuroticism in a number of studies (Bellivier et al., 2002),with depressive symptoms. 
diagnosable depression and suicidality in response to stressful life events in some, but 
not all, the cases and with the response of patients to selective serotonin reuptake 
inhibitors (SSRIs; Mann et al., 2000; Caspi et al., 2003).hi a study, dietary depletion 
of circulating tryptophan caused depressive symptoms only in subjects homozygous 
for the s-allele (Neumeister et al., 2002). 
Some patients with depression carry a polymorphism, or genetic variant, in the 
FKBP5 gene (which encodes a cochaperone of heat shock protein 90; HSP90) that 
results in higher affinity of glucocorticoid receptors for Cortisol (Binder et al., 2004). 
These individuals respond much faster to antidepressants and have a higher 
recurrence of depressive episodes than individuals without this mutation. Brain-
derived neurotrophic factor (BDNF) may have a central role in the effectiveness of 
antidepressants, but there is no firm evidence of an association of its alleles with 
major depressive disorder (Hong et al., 2003; Tsai et al., 2003; Schumacher et al., 
2005). Certain polymorphisms in the gene promoter of the monoamine oxidase an 
enzyme (involved in the metabolism of catecholamines and the target of one group of 
antidepressants, the monoamine oxidase inhibitors) are found in subgroups of patients 
with major depression or anxiety (Schulze et al., 2000; Du et al., 2004). A single 
nucleotide polymorphism in the gene of the human tryptophan hydroxylase-2 enzyme 
(involved in the synthesis of serotonin), with roughly 80% loss of function, is 
associated with major depression, but not with bipolar illness (Zhang et al., 2005). 
In regard to bipolar disorder, molecular genetic studies have reported many linkage 
loci and candidate genes. However, none of these findings have been consistently 
replicated. .Meta-analyses of linkage studies have also reported conflicting results. 
Among recently reported candidate genes, BDNF, AKTl, XBPl, G72, GRK3, 
GRIN2A, HTR4, IMPA2, GABRAl and GABRA5 may have some importance (Sklar 
et al., 2002; Hong et al., 2003; Kato et al., 2005). Among the polymorphisms of 
monoamine-related genes, some were found to cause functional alteration and to be 
associated with bipolar disorder in two or more studies. These include monoamine 
oxidase A (MAO-A; Lim et al., 1995; Rubinsztein et al., 1996; Preisig et al., 2000), 
serotonin transporter (5-HTT; Collier et al., 1996a, b; Oruc et al., 1997; Furlong et al., 
1998) and serotonin 2C receptor (5-HT2C; Oruc et al., 1997; Lerer et al., 2001). 
Catecol-O-methyltransferase (COMT) is also included in such genes, although 
association was found only for ultraultra- rapid-cycling bipolar disorder (Kirov et al.. 
1998; Papolos et al., 1998). The view that unipolar depression is under the control of 
the same genes independent of the age at onset has recently been challenged by an 
inquiry in late-onset depression: this condition was associated with a mutation in the 
methylenetetrahydrofolatereductase enzyme gene (MTHFR) in contrast to early-onset 
depression. The same mutation is predisposing to cerebrovascular diseases and is 
associated with increased plasma homocysteine and folate deficiencies which were 
also reported for late-onset depression in this context, candidate genes that are 
functionally involved in the pathophysiology of bipolar disorder according to the 
current knowledge are of interest (positional as well as functional candidate 
genes).Candidate in the linked regions are of particular functional interest and have 
therefore been explored recently: 
(1) Myo-inositol monophosphatase, a key enzyme of lithium that is encoded by the 
IMPA2 gene on chromosome 18pl 1.2, which has a role in mood disorder. 
(2) G-protein-coupled receptor kinase-3 coded by GRK3 gene on chromosome 22ql 1 
which is differentially expressed in an animal model for psychotic mania (depression). 
(3) Gene coding with multiple mutations for Wolfi^ am syndrome (WFSl), an 
autosomal recessive disease that is characterized by fi-equent comorbidity with 
affective disorders and located on chromosome 4pl6.4.Wolfi"am syndrome gene 
(WFSl) has been suggested to have a role in the susceptibility for mood disorders. A 
26-fold increased risk for psychiatric disorders in WFSl mutation carriers has been 
suggested. 
(4) Gene coding for Darier's disease, an autosomal dominant dermatological disease 
with frequent comorbidity with affective disorders on chromosome 12q23-24; this 
gene expresses the protein calcium-ATPase in the endoplasmic reticulum. 
O'Connor et al (2012), states that MicroRNAs (miRNA) are newly 
discovered class of gene -expression regulators that may represent a novel class of 
therapeutic target to treat a variety of disorders including psychiatric diseases, 
miRNAs are heavily involved in regulating many physiological processes including 
those fundamental to the functioning of the central nervous system. Evidence 
collected to date has already demonstrated that miRNA -expression levels are altered 
in patients suffering fi-om depression and anxiety and in preclinical models of 
psychological stress. Furthermore, increasing evidence suggest that psychoactive 
agents including antidepressants and mood stabilisers utilize miRNAs as downstream 
effectors.Altering miRNA levels has been shown to alter behaviour in therapeutically 
desirable manner in preclinical models. 
Background: the serotonin pathway and its transporter. 
About 18.8 million Americans adult sufferers of depression are diagnosed each year. 
Clinically diagnosed "major depression" (the type considered in this research) is 
characterized by symptoms including sadness, extreme fatigue, feelings of guilt and 
hopelessness, appetite loss, insomnia, and suicidal thoughts. In major depression, 
these symptoms become debilitating and prevent normal life activities (NIMH, 
2003).This study specifically investigates the genetic influences on episodes of this 
major depression after stress. 
Both the popular press and scientific articles that cite 5-HTT as a gene moderating 
susceptibility to depression discuss briefly the previous studies of this gene.The 5-
HTT gene encodes the serotonin transporter protein and is thus active in the serotonin 
nerve pathways. Scientists have long know that these pathways are involved in 
controlling mood, emotions, aggression, sleep and anxiety (NIDA, 2003).As a 
serotonin transporter, the protein encodes by the 5-HTT gene is responsible for the 
reuptake of serotonin into the presynaptic cells after it has been released into synaptic 
cleft to signal the adjacent neuron .The precise structure of this protein has not been 
determined, but it is known to be located in the presynaptic cell membrane.The 
activity and number of the serotonin transporter proteins determine the length of time 
that chemical signals in the synapase (Glatz, et. al. 2003}^ 
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Figure (1): Diagram of the action of Serotonin and the Serotonin Transporter. 
This diagram shows the neurotransmitter serotonin being released from the presynaptic cell 
and binding to the receptors on the postsynaptic cell. 5-HTT encodes the protein labeled 
"reuptake transporter."Image from http://psychclerk.bsd.uchicago.edu/lect-depression. 
Since the serotonin pathway and specifically the serotonin transporters, are involved 
in mood control, multiple antidepressant medications have targeted these elements, 
and researchers have often studied 5-HTT transporter for its role in depressions. 
Some previous research with this gene, presenting the previous studies as logical and 
supportive steps that preceded this research .The research studies that associate the 
5-HTT gene with anxiety in monkeys and mice and later studies that correlated the 
presence of the short allele with human anxiety after exposure to disturbing images 
(Duenwald, 2003). The previous studies do not provide conclusive evidence for the 
link between 5-HTT and depression and acknowledging that some studies had infact 
found no association between this gene and depression (caspi, et.al. 2003). 
POLYMORPHISM IN 5-HTT 
The NY Times article states that while the alleles of the 5-HTT gene called" short " 
and" long", the protein that they produce is the same - the long allele just produce 
more of the protein. The article in science explains this phenomenon by clarifying that 
the polymorphism actually does not occur within the open reading fi-ame of the 5-
HTT gene itself, but in the 5' regulatory region. Thus the terms" short and long" 
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actually refers to two different lengths of the sequences in the genes regulatory region, 
as shown in the image below 
5-HTT Long Allele 
\'XTR Region 
TATA and TF binding sites 
translated region \ 
5-HTT Short Allele 
TATA and TF binding sites 
\'XTR Region (with deletion) \ . translated region^ 
5' \ 
Figure (2).Simplifled Diagram of 5-HTT gene associated region 
polymorphism.This diagram shows the two alleles of the 5-HTT gene region. The 
transcription factor binding sites and actual translated regions of the gene are identical, but 
alleles differ in the 5' repeat (VNTR) region, image idea from Glatz et al;2003. 
The 44bp deletion in the regulatory section of the 5-HTT "Short" (s) allele occur 
Ikb upstream of the transcription initiation site of the gene (OMIM, 2003).The 
polymorphism causes decreased gene expression and fever serotonin transporter in the 
membrane of a cell. Thus, rate of reuptake of serotonin is reduced..This research tries 
to correlate this phenomenon with the development of depression (caspi et.al; 2003). 
The work by Caspi and co-workers (Caspi et al. 2003) indicated that individuals 
carrying the low-expressing, short variant of a repetitive sequence in the upstream 
transcriptional control region of 5-HTT, now commonly referred to as the 5-HTT-
linked polymorphic region (5-HTTLPR), are up to twofold more likely to get 
depressed after stressful events such as breavement, romantic disasters, illnesses or 
losing their job. (Lesch et al. 1996), moreover, early trauma inflicted by childhood 
maltreatment significantly increased the probability of developing depressive 
syndromes in later life in individuals with the short allele of the 5-HTTLPR. A 
remarkable body of evidence suggests that emotionality and stress reactivity can be 
influenced by experiences early in life, and it has long been supposed that severe early 
life trauma may increase the risk for anxiety and affective disorders (Brown and 
Harris 2008). 
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NEUROPEPTIDES IN MOOD DISORDERS 
Focus on Corticotropin-Releasing Factor 
Although evidence of a preeminent role for 5-HT- and norepinephrine containing 
circuits in the pathophysiology of depression has increased since the 1960s, an 
arguably equally impressive literature exists on the contributions of hyperactivity of 
neurons that use corticotropin releasing factor (CRF). There are the evidences that 
CRF is hypersecreted in depressed patients and discuss the potential therapeutic 
implications of these findings. Perhaps the most vulnerable finding in all of biological 
psychiatry is the increase in hypothalamic-pituitary-adrenal (HPA) axis activity in 
medication-fi-ee depressed patients. There is considerable consensus that this 
endocrinopathy is caused partly and perhaps largely, by hypersecretion of CRF, the 
hypothalamic hypophysiotropic hormone that stimulates the secretion of 
adrenocorticotropic hormone (ACTH) from the anterior pituitary gland..CRF is also 
found in extra hypothalamic areas, particularly in the areas believed to play a role in 
the regulation of effect, including the amygdala, cerebral cortex, locus coeruleus, 
raphe, and other limbic system sites. When injected directly into the CNS of 
laboratory animals, CRF produces many effects that are similar to the signs and 
symptoms observed in depressed patients. These signs and symptoms include 
decreased appetite and weight loss, decreased sexual behaviour, decreased sleep, 
increased neophobia, and psychomotor alterations. 
Effect of cytokines on mood 
There are many influences that pro-inflammatory cytokines can exert on the HPAaxis; 
however, they can also have direct effects on the brain and mood. The role of these 
cytokines is to mobilize whole body responses, including behavioural changes that 
help to fight against infection. One of the ways to accomplish this is to conserve 
energy normally expended on activity not relevant to the fight against infection. As a 
result these cytokines induce a behavioural syndrome associated with withdrawal 
from social interaction, reduced sexual activity and appetite, and increased sleep 
(Kent et al, 1992, and Danzer, 1999). Healthy people given IL-2 and TNF-a (Thl and 
pro-inflammatory cj^okines) develop depressed mood, increased somatic concern, 
cognitive impairment, and difficulties with motivation and flexible thinking (Maier 
and Watkins, 1998).These symptoms occur very quickly after cytokine administration 
and vanish soon after discontinuation of treatment, suggesting that these cytokines 
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play a causal role in induction of the symptoms. However, the dose of cytokines given 
in these experiments is very large. Although they demonstrate the principle that a link 
exists between cytokines and mood the most convincing evidence that this link is 
relevant to health comes from clinical studies. The most consistent psychological 
disturbance seen in infection (associated with increased circulating levels of pro-
inflammatory cytokines) is depression. Again, individuals who suffer autoimmune 
diseases attributed to overactive Thl activity (e.g., multiple sclerosis and rheumatoid 
arthritis) display a high incidence of depressive disorders (Dickens et al, 2002). 
Similarly depression is twice as prevalent in females as in males, and females tend to 
be Thl dominated (Kockler and Heun, 2002). Furthermore, the increased production 
of INF-.^  in the winter months has been linked with seasonal affective disorder (SAD). 
Patients suffering from SAD can often be successfially treated with high-intensity 
light therapy. Wintertime darkness is associated with more prolonged melatonin 
production (a Thl-promoting agent), which can be reversed by bright light so that the 
shift toward Thl can be minimized. Thus, the evidence is accumulating that not only 
is depression associated with raised levels of Thl activity and pro-inflammatory 
cytokines but also that these cytokines can induce depressed mood (Connor and 
Leonard, 1998). 
Comorbidity 
The use of term comorbidity has become rapidly common in reference to mental 
disorders. The concept has its origin in general medicine, where it was defined by 
Feinstein (1970) as any distinct additional clinical entity that has existed or that may 
occur during the clinical course of a patient who has the index disease under study. 
Thus the original use of term referred to co-existing but distinct disorders. 
Distinctness among, co-existing disorders may refer to separate phenomenologies, 
pathologies or etiologies. In reference to mental disorders, however distinctiveness 
among co-existing disorders often cannot be assumed at any level because of 
substantial overlap in criteria and lack of knowledge regarding the actual 
phenomenonlogy, etiology or pathogenesis of many of these disorders. For some 
disorders, it is possibly that comorbidity may be at least partially an artifact of 
definitions and overlapping criteria (Francis, Widiger, and Fyer 1990).For example, 
social phobia and avoidant personality disorder are two separate disorders in DSM -
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IV -R. However, there is clearly much overlap among the criteria for these disorders, 
and high rate of comorbidity would be expected on this basis alone. 
With regard lack of certainity about etiological -distinctness, Klerman (1990) 
noted the multiaxial systemis 'aguostic' with respect to any implications of a 
causative relationship for specific conditions listed in Axis I and II.As Klerman 
fiirther commented, the split of Axis II from Axis I personality I symptoms and 
disorders. Psychodynamic approaches, for example makes the assumption that 
personality pathology underlies and causes symptom states (e.g. a person with a 
dependent personality disorder will be vulnerable to depression following the loss of 
relationship because of the need for external supports for self-esteem).More 
biologically oriented approaches conceptualise much of the personality pathology 
classified in Axis II as subclinical forms or manifestations of Axis I, 
psychopathology.An independence model, in contrast, views the comorbidity 
commonly among these disorders as due to a nonetiological factor, such as treatment 
seeking behaviour. There are other models regarding the relationship between 
personality pathology and Axis I disorders, particularly depression, have been 
described in detail in the literature (Akiksal, Hirschfeld, and Yerevanian, 1983; 
Docherty, Fiester, and Shea; Gunderson and Phillips, 1991). 
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REVIEW OF LITERATURE 
Major dqjression is a family disorder and its familiarity mostly or entirely 
results from genetic influences. Environmental influences specific to an individual are 
also etiologically significant. Major depression is a complex disorders that does not 
results from either genetic or environmental influences alone but rather from both 
these findings are notably consistent across samples and methods and are likely to be 
generally applicable. 
SmoUer et al. (1998) studied the rate limiting step in indentitying 
susceptibility genes for psychiatric disorders which has become phenotype definition. 
The success of psychiatric genetics may require the development of a "genetic 
nosology" that can classify in terms of the heritable aspects of psychopathology.Their 
aim is to begin to apply this analysis to the anxiety disorders, focusing on panic and 
phobic disorders. Two parallel traditions of defining anxiety phenotypes are reviewed 
the first, more closely identified with clinical psychiatry, has identified categorical 
diagnoses (e.g., panic disorder and social phobia). The other, more closely identified 
with psychological studies of personality development, has examined dimensional 
traits (e.g., neuroticism) and anxious temperament (e.g., behavioral inhibition).They 
suggest that a genetic nosology of panic and phobic disorders may incorporate 
features of both traditions and discuss sfrategies of optimizing genetic approaches to 
anxiety including, 
(1) Studying phenotypic extremes. 
(2) Identifying biological trait markers and 
(3) Using animal models to identify candidate loci. 
An important dividend from the effort to define the boundaries of heritable 
phenotypes for genetic studies of anxiety may be refinement of the nosology of 
anxiety disorders. 
Hibbeln and Salem (1995) studied that lowering plasma cholesterol by diet and 
medications increase suicide, homicide, and depression. Significant compounding 
factors include the quality and distribution of dietary n- 6 and n-3 polyunsaturated 
fatty acids that influence serum lipids and alter the biophysical and biochemical 
properties of cell membranes. Epidemiological studies in various countries and in the 
United States in the last century suggested that decreased n-3 fatty acid consumption 
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correlates with increasing rate of depression. This is consistent with a well-established 
positive correlation between depression and coronary artery disease. Long chain n-3 
polyunsaturated deficiency may contribute to depressive symptoms in alcoholism, 
multiple sclerosis, and postpartum depression. They postulate long chain 
polyunsaturated fatty acids, particularly decosahexanioic acid. 
Kumar et al. (1998), examined the neuroanatomical correlation of late - onset 
minor and major depression and to compare them with similar measures obtained 
from non depressed controls. Their study groups were comprised of 18 patients with 
late - onset minor depression, 35 patients diagnosed with late - onset major 
depression, and non depressed controls.All subjects were scanned by using a 1.5 test 
MRI scanner absolute whole brain volume and normalized measures of prefrontal and 
temporal lobe volumes were obtained and used for comparison among groups. Their 
findings indicated that patients with minor depression present with specific 
neuroanatomical abnormalities that are compression with the major depression group 
but significantly different from the confrols. Normalized prefrontal lobes volumes 
show a significant linear trend with severity of depression, with volumes, decreasing 
with illness severity. Whole brain volumes did not differ significantly among groups. 
These findings Share broad implications for the biology of late life depression and 
suggest that there may be common neurobiological substrates that underlie all 
clinically significant forms of late - onset mood disturbances. 
Sullivan et al. (2000) conducted a meta-analysis of relevant data from primary 
studies of the genetic epidemiology of major depression.The authors searched 
MEDLINE and the reference lists of previous review articles to identify relevant 
primary studies. On the basis of a review of family, adoption, and twin studies that 
met specific inclusion criteria, they derived quantitative summary statistics. 
Five families' studies met the inclusion criteria. The odds ratios for proband 
(subjects with major depression or comparison subjects) versus first degree relative 
status (affect of unaffected with major depression) were homogeneous across the five 
studies. No adoption studying met the inclusion criteria, but the results of the three 
reports were consistent with genetic influences on liability to major depression five 
twin studies met the inclusion criteria, and their statistical summation suggested that 
familial aggregation was due to additive genetic effects (point estimate of heritability 
of liability = 37%, 95% CI=3% - 42%)), with a minimal contribution of environmental 
effects common to siblings (point estimate = 0%, 95%), CI = 0% -5%), and substantial 
16 
individual specific environmental effects / measurement error (point estimate = 63%, 
95% CI = 58% - 67%). The literature suggests that recurrence best predicts the 
familial aggregation of major depression. 
Dierker et al (2002) evaluated alternate familial mechanisms of comorbidity 
between depression and smoking. Methods from a case-control family study were 
selected fi-om outpatient's specialty clinics or through random-digit dialing procedure. 
A total of 133 probands and 273 directly interviewed, first degree relatives of the 
probands were included in the present analyses. 
The pattern of cross aggregation of heavy smoking and depression differed 
according to the subtype of depressive disorder. There was evidence of a shared 
etiology between dysthymia and heavy smoking, whereas major and double 
depression did not demonstrate a shared vulnerability with heavy smoking. 
Zubenko et al. (2003) described the result of the first genomic wide linkage 
survey for genetic loci that influence the development of unipolar mood disorders in 
81 families identified by individuals with recurrent, easily - onset, major depressive 
disorder (REMDD).Model fi-ee linkage was performed using genotypes for 392 highly 
informative polymorphism with an average spacing of 9cM.The highest maximum 
LOD score observed, 8.19 (genome with adjusted p « 0.0001), occurred for recurrent 
major depressive disorder (R-MDD) at D25232 (205cM), located 121 kb proximal to 
CREBl. Nineteen chromosomal regions contained linkage peaks that reached genome 
wide statistical significance (genome wide adjusted p < 0.05) and ten of these were 
"highly significant" (adjusted p < 0.001).Six of the 19 linkage peaks were revealed 
only when the analysis included covariates to control for the effects of sex and linkage 
to CREBl. 
Sex specific susceptibility loci were common and preferentially affected the 
vulnerability of women to developing unipolar mood disorders. Five loci revealed 
evidence of interaction with the CREBl focus in determining susceptibility 
(epistasis). A systematic candidate gene analysis is presented and potential overlaps of 
the linkage regions for unipolar mood disorders. 
The findings suggests that genes whose products participate in cellular 
signaling pathways that converge on CREB, as well as target genes whose expression 
they regulate, they also harbor alleles that affect the development of mood disorders. 
Levinson et al. (2003) reported on a six-site collaborative project, genetics of 
recurrent early - onset depression (GenRED).This is a study of a large sample of 
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families with recurrent major depressive disorder (DSM-IV) beginning by the age 30 
in probands or 40 in relatives. Evidence suggests that early onset and recurrence of 
depressive disorder predict substantially increased risk of depression in first-degree 
relatives compared with the general population, suggesting that susceptibility genes 
might be mapped with these phenotypes. 
Frequencies of symptoms and psychiatric and medical comorbids are 
provided. Substance abuse was more common in males, and panic disorder in female. 
Within pairs of affected siblings, correlations were significant for age at onset, 
substance abuse / dependence, panic disorder, obsessive compulsive disorder and 
nicotine initiation and persistence. They replicated previously reported associations 
among comorbid panic disorder and social phobia, chronicity of depression and 
suicidal behavior. This data set should prove useful for genetic studies of a highly 
familial form of major depressive disorders and related conditions. 
Simon et al. (2003) examined that whether major depressive disorder (MDD) 
and bipolar depressive disorder (BDD) can be distinguished by their association with 
specific types of anxiety-comorbidity individuals with a primary lifetime diagnosis of 
either bipolar disorder or major depression disorder received diagnostic assessments 
of anxiety disorder comorbidity, and completed questionnaires assessing anxiety 
sensitivity and neuroticism.The differential association of these anxiety phenotypes 
with MDD versus BDD was examined with multivariate modeling. Panic disorder and 
generalized anxiety disorder (GAD) specifically emerged amongst all the anxiety 
disorders as significantly more common on patients with BDD and MDD. After 
controlling for current mood strategy anxiety sensitivity and neuroticism did not differ 
by mood disorder type. This study supports prior research suggesting a specific panic 
disorder- bipolar disorder connection and suggests GAD may also be differentially 
associated with BDD. 
Donnell et al. (2004) aimed to explore the relationships among PTSD, 
depression, and Comorbid PTSD / depression following traumatic Injury. 
The majority of Psychopathology in the aftermath of trauma was best conceptualized 
as a general traumatic stress factor, suggesting that when PTSD and depression occur 
together, they reflect a shared vulnerability with similar predictive variable. However, 
there was also evidence that in a minority of cases at 3 months, depression occurs 
independently fi-om PTSD and was predicated by a different combination of variables 
while PTSD and comorbid PTSD/depression are indistinguishable, tiie findings 
support, the existence of depression as a separate construct in the acute, but not the 
chronic aftermath of Trauma 
Kendler et al. (2006) suggested that the personaUty traits of neuroticism and 
extroversion may be related to the HabiUty to major depression (MD).Levels of 
neuroticism strongly predicted the risk for both lifetime and new-onset of MD. Twin 
modeling indicated that the association between neuroticism and MD resulted largely 
from shared genetic risk factors, with a genetic correlation of 0.46 to 0.47 levels of 
extroversion were weakly and inversely related to the risks for lifetime and new-onset 
MD. This effect disappeared when we controlled for the level of neuroticism. Twin 
modeling produced similar results. 
Results from both longitudinal and genetic analyses support the hypothesis 
that neuroticism strongly affects the liability to MD.This association arises largely 
because neuroticism indexes the genetic risk for depressive illness. However, 
substantial proportions of the genetic vulnerability to MD are not reflected in 
neuroticism. 
Hinojosa et al.(2006) evaluated that anxiety and depression related disorders 
often appear associated and may be affected by common genetic factors. The inbred 
rat strains lewis (LEW) and spontaneously hypertensive roles (SHR) and the outbreed 
lines Floripa H and L, which more selectively bred for high and low locomotion in the 
central area of the open field (OF) test, respectively, have been proposed as 
experimental tools to study anxiety. The main goal of the present study was to 
characterize the behavior of these animals in two models of anxiety, elevated plus-
maze (EPM) and OF, in two models of depression, forced swim test (FST) and tail 
suspension test (TST) and in their home-cages. Emotionally related difference 
between LEW and SHR rats and between Floripa H and L rats were found in the 
EDM, OF and FST. Those lines showing low anxiety like profiles in the EPM and OF 
(SHR and Floripa H) also showed low immobility in the FST. The TST failed to 
unveil any line differences Factors analysis involving all tests revealed three 
independent factors with one of them associating anxiety - related measures from the 
OF and EPM to immobility in the FST. When observed in their home-cages, LEW 
and SHR rats showed no differences in general activity, but when acutely treated with 
imipramine (15 mg/kg), only LEW rats were sensitive to its antidepressant effects. 
These results suggest the existence of a genetic link between two tests used in the 
screening of anxiolytic drugs and one test of antidepressant activity. Moreover, the 
LEW and SHR rat strains were shown to be an interesting model to study the 
comorbidity between anxiety and depression related disorders. 
Ferrando et al. (2007) reported that self-administered patient health 
questionnaire - 9 (PHQ-9) is a potentially useful screening tool for depression in a 
multiple sclerosis (MS) clinic population. 
The PHQ-9 is an increasingly used clinical tool that is brief and specially 
queries the American psychiatric association's diagnostic and statistical manual of 
mental disorders IV text revision (DSM-IV-TR) depression criteria, making it easier 
for the clinical to diagnose depressive disorders .It may be useful tool in screening for 
depression in outpatients with MS (multiple sclerosis). 
Hettema (2008) reported that anxiety and depression share a long, close 
history in psychiatric nosology and treatment. The anxiety disorders individually and 
as a group, exhibit remarkably high rates of comortidity with each other and with 
major depression. Analysis done in large-scale epidemiologic surveys have identified 
major patterns of phenomenological overlap between these conditions researchers 
have tested hypothesis of shared genetic etiologies as a potential basis of this 
relationships. In general, available family studies have found mixed evidence for co-
aggregation of anxiety and depressive disorders, while twin studies more definite 
indicates that shared genetic risk factors largely account for this comorbidity. Some of 
this appears to be accounted by genetic variation in personality traits that broadly 
predispose to anxiety and depression. Molecular genetic studies of these conditions, 
though too easily to draw firm conclusions, thus for provide tentative support for 
specific genetic loci that may generally influence susceptibility across the anxiety 
depressive spectrum. 
Margoob et al. (2008) evaluated the relationship between serotonin transport 
gene promoter region polymorphism and the efficacy of SRI (Escitalopram) treatment 
in depression. Fifty seven consecutive patients with unipolar depressive episode 
(DSM rV Criteria) were genotyped for the SERT gene polymorphism and treated with 
escitalopram lOmg/day weekly assessment (HAM-D-21) was made for treatment 
response upto 6 week. 
Significant (P> 0.0001) difference between groups (II Vs.SS or IS) in response 
to treatment by escitalopram was revealed by their study.However, no differences 
with respect to age, gender, or onset of illness was observed between genotype 
subgroups. 
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The study suggests that serotonin transporter gene polymorphism may have an 
influence on the effectiveness of SSRI treatment in depressive disorders, irrespective 
of clinical variables. Further controlled studies are required to validate these results. 
Huppert et al. (2008) reviewed cross sectional and longitudinal epidemic 
logical studies related to the concurrence of anxiety disorders and depression. Results 
suggest that anxiety disorders and depression tend to co-occur in 20% to 40% of 
patients. Explanations for increased co-occurrence considered, include overlapping 
diagnostic criteria, genetics, neurophysiology, neurochemistry, negative effect 
temperament perceived, control, interpersonal mechanisms, and biases in information 
processing. According to most levels of analysis, there is more overlap to GAD and 
depression while specific phobias have the least overlap. Finally, data on the impact 
of depression on pharmacological and psychological treatments for anxiety disorders 
are reviewed. More work is needed to clarity the multiple interactive processes likely 
at play in the co-occurrence of anxiety and mood disorders and their treatment. 
Fila Kovic et al. (2009) examined depressive disorders are more common in 
the population affected with dermatologic disorders. Comorbidity of depression and 
dermatologies is around 30%. In psychodermatology three disorders are described on 
psychophysiological disorders (both disorders induced and maintained by stressors), 
secondary psychiatric disorders (mental disorder as a result of skin lesions and 
treatment) and primary psychiatric disorders (skin alterations as a result of mental 
disorders and treatment). 
Rady et al. (2010) said that post traumatic stress disorder is commonly 
overlooked psychiatric disorder to the heterogeneity of symptoms that may stimulate 
many other psychiatric disorders. Such heterogeneity of manifestations may be 
explained by the multifaceted nature of the different neurotransmitters, endocrinology 
axis, and their genetic basis, that are implicated in the etiology. Although this disorder 
has been studied from many different perspectives, its etiology is still enigmatic. 
Pompiti et al. (2010) studied to explore, the impact of mental illness among 
patients with migraine. They performed Medline and Psyc INFO secretes from 1980 
to 2008. Research has systematically documented strong directional association 
between migraine and psychiatric disorders. The relationship between migraine and 
psychopathology has often been clinically discussed rather than systematically 
studied. Future research should include sound methodologically based studies 
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focusing based studies focusing on the interplay of factors behind the relationship 
between migraine, suicide risk, and mental illness. 
Margoob and Mushtaq (2011) stated that field of psychiatric genetics hold 
great potential to contribute to the development of new diagnostic and therapeutic 
options to treat these disorders.Among a large number of existing neurotransmitter 
systems, the serotonin system dysfunction has been implicated in many psychiatric 
disorders and therapeutic efficacy of many drugs is also thought to be based on 
modulation of serotonin. Serotonin transporter gene polymorphism is one of the most 
extensively studied polymorphism in psychiatric behavioral genetics. In this article, 
they review the status of evidence for association between the serotonin gene 
polymorphism and some common mental disorders like affective disorders, post 
traumatic stress disorder, obsessive-compulsive disorder, suicide, autism, and other 
anxiety and personality disorders. While the existing information of psychiatric 
genetics is inadequate for putting into practice genetic testing in the diagnostic work-
up of the psychiatric patient, if consistent in future research attempts, such results can 
be of great help to improve the clinical care of a vast majority of patients suffering 
from such disorders. 
Rao, et al.(2011) Reported that magnetic resonance spectroscopy (MRS) is a 
unique technique that can directly assess the concentration of various biochemical 
metabolites in the brain thus, it is used in the study of molecular pathophysiology of 
different neuropsychiatric disorders, such as, the major depressive disorder and has 
been an area of active research. They conducted a computer- based literature search 
using the PUBMED database with 'Magnetic resource spectroscopy' 'MRS' 
'depression' and 'Major depressive disorder' by a manual research of bibliographic 
cross-referencing studies in depression report. Abnormalities improve after treatment 
with selective serotonin reuptake inhibitor, electroconvulsive therapy, and Yoga, and 
thus, are possibly state dependent. These finding are consistent with other 
morphometric and clinical studies and support the proposed pathophysiological theory 
of dysfunction in the neuronal circuits involving the frontal cortex, limbic contex, and 
Lasal gontia. Spectroscopy also has patient's implications in predicting the response 
to treatment and formulating individualized pharmacotherapy. 
O'Connor et al. (2012) states that microRNAs (miRNA) are newly discovered 
class of gene -expression regulators that may represent a novel class of therapeutic 
target to treat a variety of disorders including psychiatric diseases. miRNAs are 
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heavily involved in regulating many physiological processes including those 
fundamental to the functioning of the central nervous system Evidence collected to 
date has already demonstrated that miRNA -expression levels are altered in patients 
suffering from depression and anxiety and in preclinical models of psychological 
stress. Furthermore, increasing evidence suggest that psychoactive agents including 
antidepressants and mood stabilizers utilize miRNAs as downstream effectors 
Altering miRNA levels has been shown to alter behavior in therapeutically desirable 
manner in preclinical models . 
Brambilla et al. (2012) focused on the seasonal fluctuation that characterizes 
the patient's clinical course both during an illness episode and during euthymic 
periods. Sleep disturbance more problematic in unipolars when compared to bipolar. 
Sleep, light and seasonality seem to be three interconnected features that lie at the 
basis of chronobiology that, when altered, have an important effect both on the 
psychopathology and on the treatment of mood disorders. 
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M'E'DrcmoLOG'r 
METHODOLOGY 
During July to October of 2011, a survey was carried out on depression in different 
villages of Aligarh U.P (India) namely Hamdard Nagar, Dorha Mafi, Maulana Azad 
Nagar, Loco Colony, Firdous Nagar, Shahnashabad.150 patients were consulted 
during this period.PHQ-21 (Patient Health Questionnaire)was distributed in patients to 
screen out the depression and its prevalence or incidence in population .The PHQ-21 
queries each of the DSM-FV major depression criteria, including depressed mood ; 
loss of interest ;disturbance in sleep, appetite, concentration ,energy, self-confidence 
and permission , and suicidal ideation etc. The questionnaire consists of different 
questions as already above mentioned which have an option of 'yes' or No'. In other 
words, we can say patients have to answer either 'Yes' or 'No' means if the patient is 
possessing the symptoms then he or she have to choose 'Yes' and if not possessing 
the symptoms then 'No'. It should be mentioned here that villages are educationally 
backward ,then we were explaining meaning of questions to the respondent so that it 
makes easy to understood the questions and reply for it. It is for those who did not 
study at all. For those who study to some or larger extent, they reply without 
explaining the meaning of questions before them. A pedigree analysis is used in this 
study, to determine the mode of inheritance (dominant, recessive) etc. of genetic 
diseases. It should be noted children share half percent of genes from each parent. 
Therefore, genes put its influence on its traits and must run in families .Running is 
not only a matter of question but we can predict whether the trait is to be genetic or 
not. So pedigree analysis is to be used. 
In our survey work we were interviewing the patients and asked for their family 
background whether the patient is suffering from disease, was their any family 
member affected or not. The family study reveals the familial nature of a 
disease/disorder, its mode of inheritance, the range of phenotypic expression within 
the family and the intergenerational difference resulting from family dynamic genes 
and environments. The classic family study design requires the collection of a large 
sample of cases or probands, followed by systematic evaluation of relatives. 
A sample collected during survey work is valuable for many types of studies; 
Studies of rates of illness among relatives can help to define the trait/ disorder as 
heritable or non-heritable, autosomal and sex linked and its phenotypic expressions 
24 
i.e. recessiveness or dominance complete/incomplete penetrance. Diagonastic 
information was obtained from probands and relatives of probands by a semi-
structured interview based questionnaire having significant test retest reliability. 
Interviewing is of prime significance in medicine. It is an important skill in clinical 
psychogenetics as well. There is a clear difference between interviews that are free 
form and those that are standardized, the later are either fiilly structured or semi-
structured and specify to varying degrees the contents, order and wordings of the 
interview their reliability and validity can usually be specified as compared free forms 
which are non-specific. We practiced in the study a semi-structured diagnostic 
interview based on DSM- IV criteria. Every diagnostic interview includes on 
assessment of patient psychopathology including not only the formal mental status 
testing's which may be conducted but also the inferences and conclusions, which an 
interviewer draws as the interview is conducted. Besides the standard close ended 
Question (of one word answer 'Yes'or'No'). We also asked the open ended question 
(the Question having narrative answers) to predict the history of a disorders by 
inviting a proband (and sufferers relative) to give a narrative details of the course and 
chronology of his or her symptoms i.e. how did the disorder begin, was the onset 
sudden or gradual, what was the age of onset? Etc. The information gathered in this 
way helped us not only to evaluate the presence or absence of the depression and its 
types but also the patients family, work, settings, fiiends and other relationships 
which were affected by his or her illness. 
Attempts were also made to find out the possible causes of the disorders, age 
of onset, most vulnerable age groups, symptomology and frequency difference in two 
sexes, mode of transmission and influences of environmental factors etc. After the 
completion of interviews within a given family all available materials (personal 
interview data and family history descriptions) (as above mentioned) for each 
individuals were collected and best estimate diagnoses were made independently by 
psychiatrists and psychologists using DSM-IV criteria. Several levels of diagnostic 
certainty were used.When an individual had sufficient symptoms to meet almost all 
criteria a 'definite diagnosis' was assigned. If one symptom or cluster of symptoms is 
missing or there was lack of supporting information from family reports 'probable 
diagnosis' was given .Finally if some symptoms were present but not enough to 
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satisfy were present but not enough to satisfy either a probable or definite diagnoses a 
"possible diagnosis" was given. 
Definitely affected:All individuals classified as definite depressive disorder met the 
DSM-IV criteria and interviewed personally. The duration for the disorder required to 
be present for more than 4 weeks in the patients was considered as the definite 
disorder. Rarely a case that had not been interviewed could be diagnosed as definitely 
affected, but only if the best estimator felt that there was sufficiently detailed family 
history information available from multiple informants. 
Probably affected: All individuals who met DSM-FV criteria, did not qualify for 
definite affected status because either the case met most but not all definitely affected 
criteria i.e. symptom shown by them are less than definitely diagnosed patients i.e. 
they exhibit only 50% of the symptoms in comparison to definitely diagnosed 
patients, or the symptoms shown by them are not well documented. 
Possibly affected:Possible affected diagnosis was assigned to cases that clinically 
appeared to have psychiatric disorder which most closely resembled but did not meet 
fiiU criteria for the disorder. 
Unaffected or control: Individuals without any evidence of symptoms of 
depressions. All the cases diagnosed as unaffected are interviewed directly, and final 
diagnosis for all the categories discussed were made by the psychiatrists. 
Interviewers and psychiatrists wrote a narrative summary of the family history for at 
least three generations of each family and obtained records of psychiatric and other 
treatments and control. 
The present study aimed to evaluate: 
(1) What is the magnitude of familial factors in the etiology of depression and the 
other neuropsychiatric disorders like OCD, panic disorders etc.? 
(2) To what extent is the familial aggregation of depression (major and minor 
depression), OCD and panic disorders were shared initial environment? 
(3) Is there any gender specific affect in the inheritance and prevalence of the 
depression? 
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(4) Are there any qualitative difference in the role of genetic and environmental risk 
factors for reasonable or logical depression in the male females? Might the heritability 
of one depression subtype be higher in males and females and vice-versa? 
(5) Are there qualitative differences in these risk factors? That is could the genetic or 
environmental influence on depression in male differ from those which act in female. 
(6) In our survey work which were carried in a particular population the prevalence 
and incidence rate of mental and other disorders derived from surveys have important 
scientific and healthy policy implications and temperament. 
(7) Fluctuation in such rates can give clue to possible causes and can be used as base 
rates for collaborative purpose in genetics.Raw data from all available subjects were 
utilized, with the help of raw data pedigrees were constructed upto three or 4 
generations(depending upon availability) to draw conclusions about the mode of 
inheritance and prevalence of disorders. 
Statistical analysis: We apply spss v. 12 to data by which we got standard deviation 
and standard error of percentage mean of male sufferers ,percentage mean of female 
sufferers and percentage mean of total sufferers in given different localities and age 
wise. We also applied two way analysis variance to data which we collected during 
survey work .The technique comparing means of two samples is through T-test ,T-
test generally determines the significance of difference between two means .But in 
case of our data in which there are more than three samples which suggest us to 
choose more appropriate, accurate and valid test, known as F-test, which is used to 
compare more than two means of a samples .It is a technique to test homogeneity of 
means ;to test the hypothesis that means do not differ significantly. The analysis of 
variance is a method to estimate the contribution made by each factor to the total 
variation. The total variation is split up into the two following components. 
(A) Variance between columns 
(B) Variance between rows 
Total variance is due to experimental error. There are two classifications for the 
analysis of variance .When we classify the data on the basis of one factor it is 
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known as one way classification. On the other hand, Vhen we classify observation on 
the basis of two factors it is called as two way classification. We use two -way 
analysis of variance by which we calculated F-value known as F-calculated and 
compare with the F-tabulated at 5%point F-distribution or at 1% point F-distribution 
for a given degree of fi-eedom at a specific level of significance, as usual and if it is 
found that the calculated F-value concerning variation between columns is equal or 
greater than to its table value, then the difference among columns mean is considered 
significant. By calculating F-calculated and F-tabulated we have to prove null 
hypothesis (HO) which states that F-calculated or F-critical <F-tabulated, null 
hypothesis is accepted and if F-calculated> F-tabulated, null hypothesis is rejected. 
The various steps involved are as follows 
(1) Using the coding device 
(2) Take the total value of individual items (or their coded values as the case may be) 
in all the samples and call it T. 
(3) Work out the correction factor as under. 
(T)2 
Correction factor = 
n 
(4) Find out the square of all item values (or their coded values as the case be) one 
by one and then take it total. Subtract the correction factor fi-om this total to 
obtain the sum of squares of deviations for total variance .symbolically, we can 
write it as 
Sum of the squares of deviation for total variance or Total SS =Z Xf. - -^^ 
2 
J n 
(5) Take the total of different columns and then obtain the square of each column 
total and divide such squared values of each column by the number of items in 
the concerning column and take the total of the result thus obtained. Finally, 
subtract the correction factor fi-om this total to obtain the sum of squares of 
deviation for variance between columns or (SS between columns) 
(6) Take the total of different rows and then obtain the square of each row total and 
divide such squared values of each row by the number of items in the concerning 
column and take the total of the result thus obtained .Finally subtract the 
correction factor fi-om this total to obtain the sum of squares of deviation for 
variance between rows (or SS between rows) 
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(7) Sum of squares of deviation for residual or error variance can be worked out by 
subtracting the result of sum of( 4) th and( 5) th steps from the result of( 4)th step 
stated above 
(8)Degree of freedom can be worked out as under: 
d.f for total variance = (c.r-1) 
d.f for variance between columns = (c-1) 
d.f for variance between rows = (r-1) 
d.ffor residual variance = (c-l)(r-l) 
Where c = number of columns 
r = number of rows 
ANOVA table can be shown below 
Source of 
variation 
Between 
columns 
treatment 
Between row 
treatment 
Residual or 
error 
Total 
Sum of squares 
(T)2 
n 
Z-l Hj 
(T)2 
n 
Total SS- (SS 
between 
columns+ SS 
between rows) 
') n 
Degrees of 
freedom (d.f) 
(c-1) 
(r-1) 
(c-1) (r-1) 
(c.r-1) 
Mean square 
(MS) 
SS between 
columns/(c-1) 
SS between 
rows/(r-l) 
SS residual /( 
c-1) (r-1) 
SS residual 
/(c-l)(r-l) 
F-ratio 
MS between 
column/MS 
residual 
MS between 
rows/ MS 
residual 
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QUESTIONNAIRE OF DEPRESSION 
Name of the Person 
Age of the person 
Sex of the person 
Standard of the school 
Occupation of the person (If employee) 
Address 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Have you had trouble keeping your mind on things you were 
reading or watching on television? 
Have you had more trouble with your memory than usual? 
Have you feeling unusually tired every day? 
Have you found it hard to enjoy life? 
Have you had a lot of different physical symptoms or unusual 
pains? 
Have you been feeling emotionally numb not caring, sad, 
unhappy or miserable? 
Have you been feeling more pessimistic or negative than usual? 
Have you lost interest or enjoyment in the things you normally 
do? 
Have you been less motivated, less productive or found it more 
difficult to cope than usual? 
Have you been sleeping worse than usual? 
Have you been interested in talking to people or mixing with 
people than usual? 
Have you been more worried, nervous or upset than usual? 
Have you been more easily tearful, or crying more than usual? 
Have you enjoyed your food less than usual? 
Has your sexual interest been less than usual? 
Have your been less self-confident than usual? 
Have you been more anxious, nervous or worried than usual? 
Have you been more easily annoyed or more impatient than 
usual? 
Has life seemed meaningless? 
Has dying looked like a good option? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
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OBSERVATION AND RESULT 
The purpose of psychiatric genetics is complex and is given in two folds. The first is 
to decide whether the tendency for a psychoneurotic disorder/ depression is familial 
i.e. can be attributed to the genetic causes, or it is due to the environmental factors and 
second is the epigenetic factors involved in depression / psychoneurotic disorder.If 
genetic factors are involved then to identify the mechanism of gene expression and 
mode of inheritance to explain important environmental interaction. 
The first important point for supposing that a depression may be genetic is the 
observation that it aggregates in families. This aggregation is demonstrated by 
selecting a series of probands with the disorder in question and then determining 
whether the first degree (parents, offspring's and siblings) are affected more? The 
frequency of a depression in the relatives of probands is also determined by collected 
information from the probands. 
We collected a data from 150 famihes of depression from different localities of 
Aligarh. Information was gathered on at least 3 to 5 generations. We selected here 150 
probands who met DSM-IV criteria for depression. These probands and all their 
available first degree relatives and most of the available second degree relative were 
personally interviewed by using a questionnaire. Information regarding third degree 
relatives was collected from the probands and or from other relatives.This present 
study uses the method of pedigree analysis.In case of pedigree analysis all 
information contained in pedigree is used. It was observed here that if the age of 
onset in probands or any relative was low, the prominent severe symptoms were seen 
in the sufferers, the prevalence was observed to be longer and more in sufferer first 
and second degree relatives.On the other hand, if the onset was late the symptoms 
were inconspicuous and the number of sufferer relatives was also low.The total 
number of individuals studied in these pedigrees are 4473 out of which 2255 are 
males and 2218 are females. Among these total individuals, 286 were male sufferers 
and 426 were female sufferers which makes the total number of sufferers 712. 
The different localities of Aligarh where the survey was conducted are denoted by LI, 
L2, L3, L4, L5, L6 namely Hamdard Nagar, Dorha Mafi, Firdous Nagar, Shanshabad, 
Maulana Azad Nagar and Loco Colony respectively. The prevalence of depression is 
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quite prominent in shanshabad which is 19.25% and least in loco colony 13.93% as 
shown in (table 1) and histogram (A).Then we were supposed to calculate % mean of 
male sufferers, % mean of female sufferers and % mean of total sufferers of different 
6 localities and later on, by the help of ANOVA we also calculated standard deviation 
and standard error for % mean of male, female and total sufferers (table 3).Standard 
deviation and standard error was also calculated age group wise (table 4). 
It was observed that higher frequency of depression was found in females almost in 
all localities, with an age group of (21-40) years. As per the (WHO) report, the largest 
percentage of depression cases is observed in adulthood i.e. 20-40. We also observed 
the same condition. The total sufferers in this age group are 49.68% (table 4 and 
histogram B) in which females contribute 29.49 %and males 20.18% (table 4). It was 
found that depression frequency in age group 41-60 and 61 above was observed as 
25.13% and 26.14% respectively (table 4).The results are Shown in ( table 4 and 
histogram B). 
Among 150 pedigrees studied 39 pedigree showing the continuous 
expression of depression and 111 show discontinuous expression of depression. In 
locality LI and the pedigree number 6, locality L4 and pedigree number 5 , locality 
L6 and pedigree number 2,5 showing only one sufferer in each. The discontinuous 
expression showing pedigrees exceed in number very much as compared to other 
types, it shows that the gene/genes responsible for depression are either of recessive 
nature or are highly influenced by other genes and certain environmental factors for 
their expression. The total number of pedigrees showing one individual sufferer 
without history of depression is four. Inheritance of depression in first degree relatives 
is 26.20% while inheritance in second and third degree relatives is 8.57% and 3.87% 
respectively (table 6 and histogram D).The inheritance in first degree relatives was 
observed higher than the inheritance in second and third degree relatives. The 
continuous expression of depression in 39 pedigrees indicates that the disorder is 
familial in nature. The % of continuous, discontinuous and spontaneous expression of 
depression was found to be 27.30%, 70% and 2.11 respectively (table 7 and histogram 
E) .The highest percentage of discontinuous expression of depression was seen to be 
93.75 % in locality L5 and highest percentage of continuous expression of depression 
was observed in locality L3 with 71.42% and the highest percentage of spontaneous 
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depression was found in locality L4 with percentage of 6.25% (table 7and histogram 
E). Overall percentage of discontinuous expression of depression comes out to be 
higher which mean that depression trait is inherited but not expressed due to presence 
of some epistatic gene or environmental factors which are not allowing the mutant 
gene's expression and affecting the penetrance of the disorder.Next to it is continuous 
and spontaneous which is in decreasing order trend. Then we were supposed to study 
also the comorbid traits often associated with psychiatric/ neuropsychiatric disorder 
besides the depression. Comorbidity is defined as the presence of more than one 
disorder in a person overlife time, or in a certain period of time. It appears to be the 
norm rather than exception in case of anxiety disorders and depression (wittchen 
1996a).Comorbidity matters for several important reasons first, if we ignore 
comorbid disorders when studying one type of mental disorder, we may mistake 
characteristics of the disorder under study for those of comorbid conditions (kessler, 
1995; kessler and wang, 2008).Second, persons with comorbid mental disorders often 
have a poorer treatment response and a worse course of illness over time (kessler, 
1995; kavanagh, Mueser and baker , 2003), suffering more impairment, greater social 
disability and generating larger social costs. This is probably in part because 
comorbid disorders are not diagnosed and treated and in part because persons with 
more than one mental disorder are more difficult to treat. Therefore, comorbidity may 
have important implications for treatment. In general, comorbidity appears to be the 
rule among patients with depression, with two- third having at least one comorbid 
anxiety disorder (kessler et al 1996). In some studies the estimate of depressive 
patients who have comorbid panic is as high as 37-54% (Gorman 1996/97). A bigger 
community sample, however gave the more conservative estimate of 13% ( Regier et 
al 1998).Due to above mentioned reasons, we in the present study also tested our 
suffer patients for the comorbid disorders of different nature. The percentage 
comorbidities are given in (table 5 and histogram C). The comorbidity was shown 
by number of sufferers of narrow clinical types with four psychoneurotic disorders i.e. 
blood phobia, panic disorder, PTSD (post- traumatic stress disorder), bipolar 
depression and schizophrenia (table 5 and histogram C). Out of these the highest 
degree of comorbidity of depression was found to be associated with an anxiety 
disorder i.e. post traumatic stress disorder (PTSD) with an average percentage of 
(24.24%).PTSD arises due to an exceptionally stressftil life event or situation which 
is likely to pervasive distress in almost in any person e.g. disasters, wars, rapes or 
33 
torture or serious accident. It is characterized by recurrent and intrusive recollections 
of the stressful event either in flashbacks (images thoughts or perceptions) and or in 
dreams. It is also characterized by partial amnesia and anhedonia (inability to 
experience pleasure). 
The comorbidity of depression with PTSD in pedigree groups of 79-94 which 
makes a total pedigree number (16). The percentage comorbidity was found to be 
(32.10%). The comorbidity was also seen in some patients with schizophrenia. It was 
found in lowest percentage among all neuropsychiatric disorders, which contributes to 
(9.21%). A clinical syndrome with a profound influence on public health, 
schizophrenia which has been called "arguably the worst disease affecting mankind 
even AIDS not accepted" (Nature 1988). This neurological disorder is mainly 
characterized by delusions, hallucinations etc. About 10% of the first degree relatives 
and (3% of second degree and third degree relatives) of schizophrenic patients have 
schizophrenia. The concordance rate for monozygotic twins is 46% and dizygotic 
twins is 14%.If one patient has schizophrenia, the chances of the child developing 
schizophrenia increase to about 46%. Therefore genetic factors are very important in 
making an individual vulnerable to schizophrenia.However, the envirormiental factors 
are probably important in precipitating an episode of schizophrenia in some 
individuals. 
The highest percentage comorbidity was observed in pedigree group (36-48), 
and a lowest contribution in 1-35 pedigree groups. The comorbidity of depression 
with blood phobia was observed as 17.79%> in all pedigree groups, it was shown that 
highest frequency of blood phobia was observed 28% in pedigree numbers 49 to 62 
and lowest 5.26% in pedigrees numbers 95 to 100. Panic disorder contributes 18.56 % 
and bipolar depression contributes 18.24 %. It should be noted that comorbidity of 
depression with the panic disorder was found 31.25% and in bipolar depression it was 
23.35% in pedigree groups 63to78.The highest comorbidity of bipolar depression was 
observed in pedigree groups 79 to 94 with an average percentage of 23.35%). 
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Table (4):Showmg percentage mean of depression sufferers with respect to three 
age ranges of all samples. 
Age 
group 
21-40 
41-60 
Above 61 
% male 
sufferers 
20.18±4.98 
10.53±1.32 
I0.16±2.04 
Level of 
significance 
(P-value) 
P<0.05 
%female 
sufferers 
29.49± 5.27 
14.58±4.54 
I4.98±2.45 
Level of 
significance 
(P-value) 
P<0.05 
Total 
sufferers 
49.68±5.4 
25.13±5.39 
26.12±3.35 
Level of 
significance 
(P-value) 
P<0.01 
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Histogram(A) Showing locality wise prevalence of male and female sufferers of depression. 
I Male 
I Female 
21-40 41-60 61 above 
Age Groups 
Histogram(B) showing percentage mean of depression sufferers with respect three age 
ranges of all samples. 
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Depression Comorbidities 
Histogram (c) Showing percentage comorbidity of depression with other neuropsychiatric 
disorders 
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Sufferer Relatives of Probands 
• 1 Deg Relative 
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Histogram (D) showing percentage of I, II, III degree sufferer of probands. 
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Expression of Depression in pedigrees 
Histogram (E) Showing percentage of continuous, discontinuous and spontaneous 
expression of depression in the pedigrees from different localities of Aligarh 
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(DISCOSSIOO^ 
DISCUSSION 
Quantitative genetics and genetic epidemiology are the fields of population genetics 
that are of most relevance to the study of mental disorders. The purpose of 
quantitative genetics is to partition variation in the observed differences between 
phenotype into its genetic and environmental components.Genetic epidemiology is 
directly explicitly directed towards understanding the causes, distribution and control 
of diseases in groups of relatives and the inherited causes of disease in population.The 
mathematical principles of genetic epidemiology and quantitative genetics are central 
to risk analysis which is essential element in genetic counselling of familial diseases. 
Psychiatric genetics involves the application of these principles and methods to the 
study of mental disorders. 
The present study is about the depression. The pedigrees of the depression sufferers 
were analysed for three to five generations and the mode of inheritance pattern of 
depression was also observed for the depression, which is often characterized by 
feelings of hopelessness and worthlessness, feeling of inadequacy or guilt, social 
withdrawal, isolation , irritability and short temper, especially when present with 
anxiety, suicidal thoughts etc. The present study on depression deals with 150 
pedigrees upto 3 to 5 generations in order to reveal the nature and mode of inheritance 
of gene/genes of depression i.e. dominant or recessive autosomal or sex -linked, sex 
influenced or sex limited etc. 
It was seen that inheritance pattern of depression was observed to be 
continuous in 39 pedigrees. In most of the pedigrees the individuals were seen to be 
affected with depression in two or more generations. These observations evidenced 
that depression shows familial nature. Significant numbers of cases of the depression 
are observed in the first, second and third degree relatives of proband. The above 
mentioned observation provide a strong proof and suggests that depression is highly 
affected by the genetic components or factors and is familial in nature. Studies have 
carried out on such families in which the probands and other suspected members were 
diagnosed by psychiatrists and these were diagnosed by interview based on DSM-IV, 
1994 criteria. The earlier studies on the disorder were mainly based on DSM-II, 
DSM-IIIR and ICD-10 criteria. 
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Another remarkable feature of depression is that it shows comorbidity with other 
neuropsychiatric disorders, a condition in which two or more disorder occurs 
simultaneously. The present study indicates that depression shows comorbidity with 
other psychoneurotic disorders like blood phobia, panic disorder, schizophrenia, 
bipolar depression and PTSD. In our study the depression shows highest comorbidity 
with PTSD and lowest in schizophrenia. Comorbidity can be determined by using an 
approach of Kessler et al.(2005) in the national comorbidity survey replication 
sample, was to identify groups of the individual possessing distinct pattern of 
comorbidity via, latent class analysis. It should be noted that different sets or 
combinations of genetic and environmental factors involved in pure versus comorbid 
disorders, or whether the shear burden of risk i.e. level of accumulation of such 
factors may predict ones level of disease comorbidity. Major depressive 
disorder(MDD)-anxiety comorbid disorder are considered as affected cases(camp et 
al;2005).This study reported three genomic regions (3cent, 7p and 18q) with 
suggestive genome wide evidence of linkage to one or more of the phenotypes. The 
first region (3 centr)was implicated in previous linkage studies of panic 
disorder(Gelemter et al; 2001) and neuroticism(Neale et al;2005).Two other linkage 
studies analysed linkage to panic disorder plus a anxiety disorder but did not 
conclude MDD as a phenotype (Thorgeisson et al. 2003; kabbi et al. 2006). A study of 
bipolar depression identified linkage that was specific to cases with comorbid panic 
disorder in a region of chromosome 18 close to that of camp et al. study (Mackinnon 
etal;1998. 
In nut shell twin study provides a fairly strong support for shared genetic risk 
factors between major depressive disorder (MDD) and anxiety disorders, the extent of 
which depends upon the specific anxiety disorder, panic disorders and PTSD which 
are closely related to MDD followed by phobias.No data is available regarding the 
genetic correlation between MDD and OCD.Several groups of researchers have 
studied the genes of large influence which affects the occurrence of depression. 
Several candidate loci have been proposed for genetic studies in depression 
comparing the loci found in different studies on the different chromosomes,raises a 
complex picture. As per liability all the factors which influence the developmental of a 
multifactorial disorder (whether genetic or environmental), can be considered as a 
single entity known as liability.However, the risk of developing the disorder in the 
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relative of index person is directly proportional to the closeness of their relationship 
to the affected proband .We have seen this condition . The first degree relative show 
26.20% penetrance and second and third degree relative were showing 3.87% 
penetrance respectively. It is essential to note that liability includes all the factors that 
contribute to the cause of condition. A deleterious liability can be observed and 
consisting of combination of several "bad" genes and adverse environmental 
factors.Liability cannot be measured but the mean liability of a group can be 
determined from the incidence of a disease using statistics of normal distribution. 
The units of measurement of standard deviation which can be used to estimate the 
correlation between relatives regarding the incidence risk. 
(A)The prevalence of depression is greatest among relatives of most severely 
affected patients. It has been seen in depression patients that in case of any 
sufferer individual if the onset was early, the symptoms in sufferers were long 
lasting and prominent. 
(B) The risk is highest among the close relatives of the index case and decreases in 
distant relatives. The risk of first degree relative was observed as 26.20% and 
for third degree relative it was found to be 3.87%. 
(C) If there is more than one affected close relative, then the risk of the relatives is 
increased. 
Though it is difficult to assess an individual's liability for a particular disorder, it 
is possible to estimate what proportions of the etiology can be described to genetic 
factors as opposed to environmental factors. This is called heritability, which can 
be defined as the proportion of the total phenotypic variance of a condition which 
is caused by additive genetic variance. In statistics the variance is defined as the 
square of the standard deviation. Heritability is denoted by symbol h. Estimation 
of the heritability of the condition or trait provides an indication of the relative 
importance of genetic factor in its causation so that greater the value for the 
heritability greater is the role of genetic factors. Heritability is estimated from the 
degree of resemblance between relatives expressed in the form of a correlation of 
a coefficient which is calculated using statistics of the normal 
distribution. Although twin studies is not part of my work but it is a good method 
to determine heritability. It is ampi-clear that depression is genetically a complex 
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disorder, polygenic and epistatic much like heart disease, hypertension, diabetes 
and cancer (Lander and Schork 1994, Sullivan et al., 2000). 
Depression with recurrent episodes and possibly early onset may have higher 
genetic influence and may be thus associated with greater familial aggregation 
(Sullivan et al 2000). Traditional genetic linkage studies and candidate gene 
methods have been used with efficiently success in major depression genetic 
model of etiology generally assume a large number of genes with a small 
contribution to liability. 
We have found in our present data that prevalence or incidence of 
depression rate in women is higher than men as already mentioned. In other words 
we can say that women are more susceptible to depression.This may be due to 
involvement of some genetic factor in the etiology of depression. More number of 
women as compared to men was suffering from depression in given different 
localities as seen in pedigrees analysis. 
In five regions containing significant linkage peaks (10p,10q25-26,llq,19p,19 
pericentric), the LOD scores observed were significantly higher in the subset of 
families that exhibited linkage to CREBl than remaining families (2q^).This 
observation implies that the susceptibility genes in these regions interacts with 
CREBl to increase the risk of mood disorders in these families are examples of 
epistatis.In contrast, LOD scores observed for the linkage peak on chromosome 
5q21-23 were significantly higher for males ARPs and were not influenced by 
CREBl, findings that suggest the susceptibility locus in this region participates in 
a separate pathogenic pathway. 
Sex specific effects on the expression of the identified susceptibility loci were 
common and were substantially more likely to affect the vulnerability of women 
than men to developing unipolar mood disorders. Five loci revealed significant 
sex-specific effects [2q (2), 4q, 5q, Xq], four of which resulted in greater evidence 
linkage in women. 
As described above, five additional loci produced interactive effects on the 
susceptibility in concert with CREBl, (CAMP responsive element binding protein 
1), is a pE€>teHrfhaNH4^humans is encoded by the CREBl gene, a locus with sex-
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limited effects in women. These findings suggest that there may be important in 
the molecular pathophysiology of mood disorders in men and women or the 
mechanism that determine resilence to endogenous or environmental 
depressogenic stimuli. These sex-specific susceptibility loci may atleast partially 
explain the increased population prevalence of recurrent onset of major depressive 
disorder (R-MDD) among women. They may also contribute to the vulnerability 
to develop mood disturbances during times of significant hormonal fluctuation 
including puberty, menstrual cycling, pregnancy and child birth and menopause. 
Conversely, age related reductions in the levels of sex-hormones may contribute 
to the reduced proportion of familial cases of MDD among those that first emerge 
in later life, due to in part to the waning effects of sex-specific susceptibility 
genes. 
In addition to the Camp signalling pathway, growth factors and stress signals 
stimulate the CREB-mediated transcription by promoting the phosphorylation of 
CREB (Mayr and Montminy, 2001) and may also contribute to the molecular 
cascade that influence the development of mood disorders and related conditions. 
This hypothesis led to the systematic search for candidate genes that encode 
proteins that participate in signalling pathways that converge on CREB as well as 
a sample of target genes whose expression is regulated by CREB. There are some 
overlapping candidate genes encode neurotransmitter receptors, enzymes that 
participate in the neurotransmitter metabolism.G-protein receptors and regulators, 
enzymes that participate in the metabolism of growth factors and receptors 
especially Fibroblast growth factor (FGF) and Fibroblast growth factor receptor 
(FGFR); CREB - kinases,CREB and CREM; and target genes whose product 
participate in the broad range of cellular functions.These results suggest that this 
may be a profitable approach to identify additional candidate genes for mood 
disorders. 
Information regarding the fimctions of candidate genes may also contribute to an 
understanding of clinical biology of the resulting disorders.Alteration in CREB 
expression have been reported in the nucleus accumbens (mood, pleasure, 
addiction) and hippocampus (cognitive features) of animal models of MDD and 
related disorders in clinicopathological studies of temporal cortex from patients 
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with MDD and in the brain of rodents and tissues of patients treated with anti-
depressent drugs (Rossby and Sulser, 1997; Vaidya and Duman, 2001; Nestler et 
al., 2002).Besides this disturbances in signalling pathways that converge on 
CREB may result in altered circadian rhythms and distribution in hypothalamic -
pituitary adrenal axis through resulting dysregulation of the CREB target genes 
PERI,a clock gene that controls circadian rhythms in mammals (Travnickova 
Bendova et al; 2002) and CRF, the gene for corticotropin releasing factor. 
Alteration in the expression of CREB target genes that participate in glucose and 
energy metabolism may contribute to changes in weight, appetite and brain 
glucose utilization that occur in depressed patients.CREB has also implicated in 
neuronal plasticity, cognition, and long term memory (weber and sweat 2002). 
Impairment in these processes commonly occur in patients with MDD, may 
predispose patients to the onset or recurrence of MDD, and may be associated to 
the eventual development of irreversible dementia in some patients (zubenko, 
2002; zubenko et al. 2001). CREB regulates the expression of numerous genes 
that participate in cell division, cell survival and cellular repair mechanism, 
disruption of which may lead to neurodegenerative events. 
Reports says that there are some interactions of CREB and CBP with nuclear 
estrogen receptors (Lazennce et al; 2001; Mc Ewen, 2001; Tremblay and Giguere, 
2001) may provide a mechanism by which CREB and other genes produce sex-
specific patterns of gene expression that manifests themselves as mood disorders. 
The role of case control studies in strategies to identify susceptibility genes for 
multifactorial human disorders whose genetic underpinnings are non-mendelian is 
controversial .It should be noted the possible involvement of the CREBl locus in 
mood disorders was initially identified by a case control study that revealed a sex-
specific association of the 124 bp of D2S2944 (210cM) with RE-MDD (Zubenko et 
al; 2002c) 
Several variants of other functional candidate genes were identified which 
could be among the genetic risk factors for depression may actually relate primarily 
to genetic risk to disturbed sleep as shown in allelic variation of TPH2 (Tryptophan 
hydroxylase) in females. Amongst the genes that are involved in serotonergic 
neuroti-ansmission, variants from TPH2, SL6A4, COMT, and MAOA were studied. 
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Previous studies have found evidence for an association of variants from the exon T 
and intron 8 regions of of TPH2 gene with suicide in MDD (ke et al.,2006,lopez de 
lara et al.,2007),schizoaffective disorder, suicide attempt(Zang et al., 2005), and with 
bipolar disorder (lopez et al., 2007). Thus result by others and in support of the 
probability of an involvement of S'region of TPH2 in the regulation of mood. 
An allelic variant of 5-HTTLPR may predispose to depression in individuals 
with stressful life events (Mc caffery et al., 2006; Uher and Mc Guffm, 2008).For all 
of the genes studied from serotonergic system, association were observed only with 
females), which may relate to variable regulation of gene expression in two genders, 
as expression of serotonin transporter genes is modified by sex hormones (Gubbels 
Bupp et al; 2008).Amongst the gene involved in the glutamatergic, neurotransmitter 
variants of GAD 1, P2RX7, DAOA and GRIA3 were studied by various workers from 
time to time.GRIA3 was associated with depression , depression accompanied by 
early morning awakenings, and fatigue in females.A major haplotype of GR1A3 was 
associated with depression in females.GRIAB has previously been identified in Italian 
population among female patients with schizophrenia (Magri et al.,2008).For GADl, 
rsl2185692 in the promoter region showed evidence of association with depression 
and depression accompanied by fatigue in females. 
Previous studies suggested a role for the promoter region of GADl in bipolar 
affective disorder (Hettema et al., 2006). Association studies have repeatedly found 
the involvement of BDNF polymorphism (val66 met) in psychiatric diseases. In 
other population based studies, an association of the val66 (valine) allele with bipolar 
depression and with MDD (and its related personality traits) was observed (Neves-
Pereira et al., 2002; sklar et al., 2002; sen et al., 2003; Green et al., 2006). Another 
variant of BDNF from promoter region, rsl 491850, also showed nominal evidence of 
association with depression in females. The NTRK2 gene has a complex genome 
organization, spanning 350 kb and containing multiple splicing isoforms with the 19 
exons. Therefore, it is possible that there are no causative risk variants for depression 
and disturbed sleep in any of the SNPs tested, and thus these variants remain to be 
found in NTRK2. 
Amongst the genes from HPA-AXIS, nominal evidences of association for 
the intronic variant rsl73365 of CRHRl with depression accompanied by eariy 
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morning awakenings in females was found.The same allele has been associated with 
adult depression arising from childhood abuse (Bradely et al., 2008) suggesting that 
dysregulation of the HP A- axis is one of the major neuroendocrine abnormalities in 
depression. 
The role of circadian genes in the etiology of depression, as is already 
mentioned about one clock gene namely PERI, besides this some other clock genes 
are also involved in the causation of depression. It should be property noted here that 
shortage of light may trigger the seasonal fluctuation which is common in a number 
of patients with mood disorder(shin et al., 2005; Grimaldi et al., 2009) and mutations 
in circadian genes are linked with metabolic syndrome(Turek, 2008) 
Strong evidence was found for allelic variants of TIMELESS gene in both 
females and males. One of the four SNPs of TIMELESS examined rs7486220 in the 
intron one region showed the strongest association with the minor allele 'A' which 
increases the risk for depression in females. In males, the SNPs rs 1082214 in the 
promoter region associated with the depression was accompanied by early morning 
awakening with associating minor allele 'T'.Thus the allele 'T' was associated with 
depression. This allele might increase the risk for symptoms of distributed sleep like 
early morning awakenings and fatigue, and in this way it may also impact on risk for 
depressive disorder. Earlier studies have indicated evidence for association between 
SNPs at the circadian gene loci and bipolar disorder, schizophrenia (Mansour et al; 
2006), insomnia and mania (Shi et al., 2008). The major allele 'G' of the SNPs 
rs2291738, located in the intron 22, was shown to be associated with D+ FAT+ in 
females, and to be one of the allele which is associated with the bipolar depressed 
patients (Mansour et al., 2006).These findings thus confirmed the involvement of 
TIMELESS with susceptibility mood disorders (depression). 
It should be noted that TIMELESS is involved in cell survival after DNA 
damage (Unsal-kacmaz et al 2005), and is essential component of in the regulation of 
the circadian rhythm.It interact with PER proteins in the cytoplasm and form a 
hetrodimer complex, thus allowing their entry into nucleus where they inhibit the 
ARNTL- clock and ARNTL - NPAS2 complex, which induces the transactivation of 
PERI (Sangoram et al., 1998). This interaction may point to a genetic network that 
controls elements of circadian system, which are involved in mood disorder i.e. 
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depression. Besides to, TIMELESS gene, polymorphism from ARNTL, CRY2, 
RORA, NFIL3, CSNKIE, ARNTL2, NPAS2, TIPIN, and PERI indicated associations 
with depressive and sleep related problems. 
It has been observed that certain polymorphism in the gene promoter of the 
monoamine oxidase an enzyme involved in the metabolism of catecholamines and 
the target of one group of antidepressants ,the monoamine oxidase inhibitors are 
found in the subgroups of patients with major depressions or anxiety (Schulze et al., 
2000; Du et al, 2004). 
A polymorphism in the catechol-o-methyl transferase COMT; another catecholamine 
metabolizing enzyme is associated with treatment response to mitrazepine, but not to 
paroxetine in major depression (szegedi et al., 2005).A recent search for 
pharmacokinetics effects of cytochromes CYP2D6 and CYP2C19 alleles suggested 
that for 14 out of 20 investigated antidepressants atleast one doubling of the dose 
would be needed in extensive metabolizers compared with poor metabolizers. This 
variation in effects does strengthen the argument for antidepressant plasma 
monitoring in depression resistant to treatment (kircheinner et al., 2001). 
If the clinical feature of the MDD and related conditions reflects the aggregate effects 
of numerous late genes, it may not be accidental that antidepressant medications 
stimulate multiple neurotransmitter receptors that lead to activation of 
CREB.Elecroconvulsive therapy; the single most effective treatment for severe 
depression is also likely to activate CREB through stress activated-kinases (Duman 
and vaidya, 1998). This is an efficient mechanism for stimulating the expression of 
broad spectrum of CREB target genes that may be relevant to the clinical expression 
of mood disorders, although one that is somewhat lacking in specificity and has been 
prone to generations of side effects. It may prove challenging to design 
antidepressants (or other treatments) that act at the level of one or few of these late 
genes, with the goal of reducing side effects, and still retains efficiacy against the 
entire syndrome of MDD and its comorbid conditions. 
There are some other therapeutic approaches implicated for the treatment of 
depression. Antidepressants alternatives are available now-a-days for a purpose to 
treat depression. There are some natural antidepressants. Among the natural 
antidepressants St.Johns wort, DHEA, and omega -3-oils, SAM-E is the ray of hope 
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for depression sufferers to alleviate from it. St. Johns Wort is a little weedy herb that 
grows fast in the warm climates.Although it tastes quite bitter, all parts of plant are 
used as herbal remedy for depression. Today it is available in the form of pills, teas 
and food, but it is not FDA regulated. It modulates five different neurotransmitter 
activities. First it contains a slight serotonin uptake blockade, the same mechanism 
with which the SSRIs and MAOIs gives advantage. It also directly interacts with the 
neurotransmitter glutamate and GABA.DHEA (dehydroepianodrosterone) is another 
'nonapproved antidepressants' which alleviates depression. It is known that Cortisol 
levels are higher in depressed people. So, it inhibits Cortisol stress hormone shown to 
decrease neuronal birth. Omega- 3-oil (eicospentaenoic acid) is also suggested if 
depressed patients diet seems low in them. SAM-E is s- adenosylmethionine. It also 
acts natural antidepressant. The most therapeutic approach to treat depression is 
lithium i.e. lithium carbonate (Li2C03) which is currently a drug of choice for 
treatment of severe depression, bipolar depression and prevention for further episodes 
of schizophrenia. 
CTs might affect mood cycling by altering circadian clock gene signalling, lithium 
provides clue to it. Lithium's two major clinical benefits are as (a) neuroprotective 
agent that promotes axonogenesis and reduces apoptosis and (b) as a mood stabilizer. 
Its benefits may be mediated by the dual effects of lithium-mediated GSK3B and 
REV-ERBa inhibition. Lithium affects the phosphorylation of GSK3B and REV-ERB 
a, two key elements of interacting clock gene feedback loops. In the primary loop, 
lithium inhibits GSK3B and delays the circadian clock in part by reducing PER 
phosphorylation. The delayed nuclear entry of PER and CRY protein following 
lithium treatment is associated with a delayed clock timing. In a secondary loop, 
lithium-mediated inhibition of GSK313 reduces phosphorylation of the clock protein 
REVERBa, a negative feedback component of a secondary clock loop, resulting in 
disinhibition of negative feedback on 5Ana/7.This disinhibition enhances Bmall 
activity and shortens the cycle duration of this secondary loop. Lithium may have 
opposing effects on these two interacting loops: lengthening the intrinsic cycle 
duration of the primary feedback loop and shortening the intiinsic cycle of the REV-
ERBa regulatory loop. These opposing actions of lithium may strengthen the 
interaction between these feedback loops and contribute to its mood stabilizing 
effects. Through their Gsk3B inhibiting effects, the mood stabilizers VPA and 
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lamotrigine are predicted to have similar effects; CTs and antidepressant drugs, 
because they often increase Gsk3fi levels, are predicted to have mood destabilizing 
effects. While lithium appears to stabilize mood cycles, the effects of CTs may be 
more complex and may alter mood as well as destabilize mood cycles. CT induced 
changes in monoamines (signalling pathways common to chronotherapeutics and 
psychoactive drugs) may also affect intracellular signalling cascades via effects on 
GSK3B, one of several gateways for affecting clock gene signalling by monoamines. 
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CONCLUSION 
• It is a complex multifactorial disorder which relates to a number of genetic 
and environmental factors. 
• The depressive disorder is familial and more cases of the depression were 
observed in relatives of probands than in control. 
• Data suggest that the first degree relatives of the sufferer parents have greater 
risk of having depression as compared to second and third degree relatives. 
• The inheritance pattern in first, second and third degree relatives of depression 
suggested that the gene/genes show significant penetrance and expressivity. 
However the inheritance is not showing Mendelian trend. Out of 150 
pedigrees 111 are showing discontinuous expression as though the genes are 
recessive and 39 pedigrees showing continuous inheritance, suggesting the 
dominance of genetic factors. These conditions suggest the polygenic nature 
of this disorder; the previous genetic studies are also describing a number of 
loci i.e. [2q (2), 4q, 5q, Xq], involved in the inheritance of depression. Like so 
many other polygenic traits, depression genes are also sensitive to a number of 
environmental factors for their expression. This is the reason perhaps that due 
to these environmental influences sometimes the expression is continuous and 
sometimes it is discontinuous. Besides the gene interactions and epigenesis 
could also be involved in influencing these genes ( both in negative and 
positive directions).The gender wise difference in the expression also confirms 
that the gene expression of this disorder is intensified in the presence of 
female hormones and may not be affected much by male hormones. 
• The present study demonstrated that depression is more prevalent in females 
as compared to males. The frequency of depression in females is greater than 
males.It is trust worthy that present data which shows enormous female 
sufferers frequency which indicates that depression is sex-influenced trait. In 
the present data by applying S.D and F-test to compare the F-value of male 
and female sufferers i.e. F- calculated compared with F- tabulated at given 
level of significance (p<0.05, p< 0.01).The comorbid fraits like blood phobia, 
bipolar depression, schizophrenia, PTSD and panic disorder was also observed 
in given pedigrees in which the depression shows comorbidity with other 
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neuropsychiatric disorders. The PTSD shows higher comorbidity followed by 
panic disorder, bipolar depression, blood phobia and least in schizophrenia. 
• Evidence from previous epidemiological studies has suggested that the 
regulation mechanisms of mood disorder (depression) are genetically linked. 
Various candidate genes, for example TPH2, GAD] or CRHRl in females, 
displayed an association with depression when the disorder was accompanied 
by symptoms of disturbed sleep. 
• Most of the patients with major depression have deranged sleep patterns, 
leading to symptoms such as decreased or increased total sleep, frequent 
nocturnal awakenings, difficulties falling asleep, early morning awakenings, 
and fatigue. 
• Earlier studies of depression have provided evidence for an imbalance in 
neurotransmission in various regions of the brain; however, the precise 
mechanisms as well as the molecular etiology of depression are as yet largely 
unknown. Further investigation is needed to identify relevant factors that 
trigger the onset of the disorder. 
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SUMMARY 
Depression is a complex psychiatric disorder that comprises a variety of symptoms, in 
addition to depressed mood state, including indications of disturbed sleep such as 
early morning awakenings and fatigue. Poor sleep has been demonstrated to be one of 
the modifiable risk factors in the onset of depression. Neurobiological and molecular 
genetic studies of depression have introduced a number of candidate genes. In present 
study a survey work which was carried in different villages of Aligarh, 150 families 
were studied d\iring survey. We were supposed to interviewed them and patients had 
to answer for the PHQ-21.The patients were supposed to fill the questionnaire which 
consists of 21 different questions.The data was collected and pedigree were 
constructed. A thorough analysis of these pedigrees was done, observing the 
continuous, discontinuous and spontaneous expression of depression in the proband, 
first, second and third degree relatives of proband etc.Gender wise analysis of 
sufferers and comorbidity with other mental and non-mental disorders were also 
considered in the sufferer males and females. Standard deviation and standard error 
of mean were calculated by using SPSS V.12 and it was subjected to two way 
analysis of variance (ANOVA) by which F- value of male and female sufferers was 
calculated at given level of significance (p<0.01 or p<0.05).The result of present 
study are quite similar with some of the previous studies on depression.The main 
findings are that the depression is a polygenic disorder.The prevalence of depression 
was quite predominant in females as compared to males.lt was observed that first 
degree relatives of proband were more affected with depression as compare to second 
and third degree relatives which is also confirming its genetic basis.In our work the 
depression shows comorbidity with other neuropsychiatric disorders like blood 
phobia, panic disorder, post-tramuatic stress disorder(PTSD),bipolar depression. The 
PTSD shows highest comorbidity and least in schizophrenia. 
The results indicate that depression is heterogeneous and that its genetic background 
may be partly different in women and men. This study also shows that the regulation 
of depression has genetic backgrounds involving mechanisms of glutamatergic 
neurotransmission. 
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future (Directions 
FUTURE DIRECTIONS 
Flow chart of the process for discovering candidate vulnerabiHty genes by using 
microarray technology in major depressive disorder (MDD) are given below. 
Step Description 
> Acquire and characterize high-quality postmortem brain tissue; match patients 
and comparison subjects. 
> Process and store tissue. 
> Dissect multiple disease-implicated brain regions. 
> Extract total RNA from tissue. 
> Evaluate RNA quality. 
> Prepare microarrays and brain tissue samples. 
> Run Affymetrix Gene Chips or spotted cDNA microarrays in two independent 
laboratories; evaluate data and rerun samples on low-quality chips. 
> Validate cellular localization of microarray results by using real time 
polymerase chain reaction and in situ hybridization. 
> Analyze data and statistical approaches for stringent criteria for significance of 
differentially expressed genes between tissue from patients and comparison 
subjects; compile list of candidate genes that meet criteria. 
> Determine functional significance of each identified candidate gene by using 
web based data review. 
> Cluster genes functionally in terms of known metabolic and signaling 
pathways. 
> Evaluate identified candidate genes in terms of their chromosomal locus and 
possible overlap with replicated microsatellite whole genome scan "hot spots" 
of mood disorder and schizophrenia patients. 
> Determine overlap of the candidate gene list with genes identified in 
microarray studies of animals receiving psychoactive drugs. 
> Redo entire experiment with new cohort of patients and matched comparison 
subjects. 
The greatest benefit from genetic research is likely to come in the development of 
platforms for drug discovery and for understanding the genetic contributions to drug 
action. Because genes are the blueprints that code for the protein building blocks of 
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cells, the discovery of alleles that confer vulnerability to depression or other diseases 
will direct attempts to compensate for the resulting alterations in expression pattern or 
function of the affected protein. Moreover, because proteins interact with one another 
within cells, identification of vulnerability genes will direct attention to biochemical 
pathways that could provide multiple targets for new therapies. Many pharmaceutical 
companies are now intensely interested in the search for complex disease genes. 
Given a conservative estimate of 500-1,000 unique genes that contribute to risk for 
100 important multifactorial diseases, and with each gene product interacting with 3 -
lOother proteins in the signaling pathways, approximately 3,000-10,000 interesting 
new molecular sites for intervention (drug targets) are expected to emerge over the 
next few years compared with the roughly 500 targets on which today's drug 
therapies are based.If 10 genes influence the risk of depression, there may be 30-100 
interesting new drug targets. Many biotechnology companies are mining large 
genetic.EST and SNP databases to gather information on gene coding regions and to 
look for previously unknown proteins that may be new drug targets. Once promising 
genes are identified, the protein products are screened in cells and animals. DNA 
arrays are now available to simultaneously analyze thousands genes expressed in the 
brain. Such profiles will reveal in which cells or tissues these genes are up or 
downregulated and under which specific environmental or developmental conditions. 
Candidate target scan be specified and subsequently expressed. The opportunity to 
compare the expression of thousands of genes simultaneously between disease and 
normal tissues or in animal models before and after some manipulation will allow the 
identification of multiple new drug targets.The proteins thus isolated can be used to 
develop appropriate screening assays, which can then be followed by combinatorial 
chemistry techniques and high-throughput screening to develop and test a large 
number of new compounds. 
In addition, genes will be identified that control the activation, distribution, and 
elimination of many drugs used to ti-eat clinical disease.Mutations in a given gene lead 
to variations in the amount of the protein synthesized, its properties, and its final 
destination. Such genetic mutations may produce a variant protein that can cause an 
altered drug response; hence, proteins are the direct link between genetic constitution 
and individual-specific drug response. The emerging field of pharmacogenomics is 
concerned with genetic effects on therapeutic drugs themselves and with the genetic 
variation that contributes to the variable effects of drugs in different individuals. 
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Following genomic tools given in table (A) will be studied in fiiture in Major 
depression (MD). 
Table (A) 
Tool 
Genetic maps 
SNPs 
Genome- wide 
association 
analysis 
Complete human 
DNA sequence 
Full - length 
cDNAs 
DNA arrays 
Genomic tools to be applied in the study of major depression 
Description' 
Physical and genetic maps of ESTs 
and STSs 
Sequence variation at a single 
nucleotide base 
Analytic method to search for 
differences in the frequencies of 
specific genetic variants 
Finished sequence of the genome, 
including the identification and 
location of all human genes 
DNA sequence complementary to 
mRNA, containing the entire 
protein coding sequence of a gene 
An ordered set of DNA molecules 
used for the automated matching of 
known and unknown DNA 
samples, based on base pairing 
rules 
Application 
Discover vulnerability 
genes 
Discover vulnerability 
genes; identify new drug 
targets 
Discover vulnerability 
genes 
Discover vulnerability 
genes; identify drug targets 
Study gene expression 
pattems in the brain; 
understand gene and 
protein function 
Study gene expression 
profiles; screen for disease 
mutations; discover and 
score SNPs; 
simultaneously genotype 
hundreds of SNPs; 
indentify new drug targets 
Note, ESTs = expressed sequence tags; SNPs = single nucleotide polymorphisms; STSs 
sequence tagged sites. 
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